• Thrombosis, DVT and anticoagulation therapy; Atrial Fibrillation in people undergoing Percutaneous Coronary Intervention (PCI); Heart Failure and anticoagulation; medically ill patients and anticoagulation; cancer and anticoagulation.
  • Metabolism: Renal physiology associated with SGLT2 mode of action with emphasis on Chronic Kidney Disease; Role of SGLT2i in Cardiovascular Disease with emphasis on Heart Failure, CVOTs and Cardiac Death; and Patient engagement.
  • Other Areas of Interest: Real World Data (RWD) and what it means; The complex patient with diabetes and CVD.